Truist Securities Lowers Aveanna Healthcare's Price Target to $5.00, Analyst Maintains 'Hold' Rating

Truist Securities has revised its price target for Aveanna Healthcare Holdings (AVAH) to $5.00 from $6.00, a 16.67% decrease. The analyst firm maintains its "Hold" rating. The average one-year price target from 8 analysts is $5.84, with an average brokerage recommendation of 3.1, indicating a "Hold" status. The estimated GF Value for AVAH is $2.60, suggesting a 34.34% downside from the current price.

On July 2, 2025, Truist Securities revised its price target for Aveanna Healthcare Holdings (AVAH) from $6.00 to $5.00, representing a 16.67% decrease. The analyst firm maintained its "Hold" rating on the stock. This adjustment comes amidst ongoing market fluctuations and evolving industry dynamics.

The new price target of $5.00 is based on the average one-year price target from 8 analysts, which stands at $5.84. The average brokerage recommendation from these analysts is 3.1, indicating a "Hold" status. This suggests a cautious outlook on the stock's future performance.

GuruFocus estimates the GF Value for AVAH to be $2.60, suggesting a potential 34.34% downside from the current price. GF Value is calculated based on historical multiples and future performance estimates, providing a measure of the stock's fair value.

The revised price target and rating reflect Truist Securities' assessment of Aveanna Healthcare's current market position and future prospects. The company operates as a diversified home care platform, providing pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform aims to minimize the overutilization of high-cost care settings.

Institutional investors and hedge funds hold a significant portion of Aveanna Healthcare's stock, with 87.96% of the shares currently owned by these entities. Recent insider transactions have also indicated a decrease in ownership, with major shareholders selling shares in recent months.

The market response to this update has been mixed, with shares of AVAH trading down 2.4% on July 2, 2025, hitting $3.95. The stock's 50-day and 200-day simple moving averages stand at $5.10 and $4.85, respectively. The company's market capitalization is $769.63 million, with a PE ratio of 197.25 and a beta of 1.98.

References:
[1] https://www.marketbeat.com/instant-alerts/truist-financial-has-lowered-expectations-for-aveanna-healthcare-nasdaqavah-stock-price-2025-07-16/
[2] https://www.gurufocus.com/news/2981630/citigroup-c-maintains-buy-rating-as-price-target-raised-by-truist-securities-c-stock-news